O. Tsygankova, O. Timoshchenko, O. V. Tuzovskaya, L. Latyntseva, K. Nikolaev
{"title":"SGLT2抑制剂在心力衰竭合并糖尿病、非酒精性脂肪肝和贫血患者中的潜在新应用点(文献综述)","authors":"O. Tsygankova, O. Timoshchenko, O. V. Tuzovskaya, L. Latyntseva, K. Nikolaev","doi":"10.18699/ssmj20220601","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":33781,"journal":{"name":"Sibirskii nauchnyi meditsinskii zhurnal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review)\",\"authors\":\"O. Tsygankova, O. Timoshchenko, O. V. Tuzovskaya, L. Latyntseva, K. Nikolaev\",\"doi\":\"10.18699/ssmj20220601\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":33781,\"journal\":{\"name\":\"Sibirskii nauchnyi meditsinskii zhurnal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sibirskii nauchnyi meditsinskii zhurnal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18699/ssmj20220601\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sibirskii nauchnyi meditsinskii zhurnal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18699/ssmj20220601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature review)